STRA6 regulates tumor immune microenvironment and is a prognostic marker in BRAF-mutant papillary thyroid carcinoma
Weiman He(Sun Yat-sen University), Haipeng Xiao(Sun Yat-sen University), Yijia Sun(Sun Yat-sen University), Bo Lin(Sun Yat-sen University), Yanbing Li(Sun Yat-sen University), Xuejie Wang(University of California, Irvine), Jiawei Ge(Sun Yat-sen University), Shuang Yu(Heilongjiang University of Chinese Medicine), Shubin Hong(Sun Yat-sen University)
Cited by 15
Related Papers
Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4
|Journal of Clinical Investigation|2010|165
Association of Total Thyroidectomy or Thyroid Lobectomy With the Quality of Life in Patients With Differentiated Thyroid Cancer With Low to Intermediate Risk of Recurrence
|JAMA Surgery|2021|116
METTL3-m6A-Rubicon axis inhibits autophagy in nonalcoholic fatty liver disease
|Molecular Therapy|2021|108
<i>MiR-195</i>Inhibits Tumor Growth and Metastasis in Papillary Thyroid Carcinoma Cell Lines by Targeting<i>CCND1</i>and<i>FGF2</i>
|International Journal of Endocrinology|2017|91
Scutellarin Prevents Angiogenesis in Diabetic Retinopathy by Downregulating VEGF/ERK/FAK/Src Pathway Signaling
|Journal of Diabetes Research|2019|70